the same level, slightly increased. Moreover, there were major overhaul maintenance of Sriracha plant and planned maintenance of IRPC-CP, plus the drop in dividend income from Ratchaburi Power Company
result was increased by Baht 75 million due to higher wind speed, comparing to the same period of previous year, leading to higher electricity generation. NTPC: Unit : Million Baht 2018 2017 Change
Q3’2019 BGRIM announced Q3’2019 result with a record normalized net profit (NNP) of Baht 1,225 million and NNP-owner of the parent of Baht 715 million, surging 69.0% from the same period of last year (y-on
by 39.71% comparing to THB 427.91 million of the same period last year (“QoQ”). Revenue from steel tower manufacturing decreased by 52.25% QoQ as a result of decreasing in number of unit deliverables
tons or 11% compared to FY2018 due to the incremental capacity of methyl ester from methyl ester plant 2 which has commenced the commercial operation in 2Q2019. In addition, at the same time, the company
to the same period of the previous year. Gross Profit and Gross Profit Margin EMS business The Company had gross profit from EMS business for 2019 amounting to Baht 264 million, which was decreased by
display, cost of sample products, expense on advertisement media such as TV media, online media, etc. At the same time, salary, bonus, welfare and commission fee for sales staff increased by about Baht 4.74
Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th media, online media, etc. At the same time
23.19 48.14 Cash Flow from Operating Activities CFO as of December 31, 2019 was 200.06mb, closing at the same amount last year. The management will consider using the surplus CFO in investment or any